NF-?B Blockers Gifted by Mother Nature: Prospectives in Cancer Cell Chemosensitization

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|22|27|4173-4200

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.22, Iss.27, 2016-08, pp. : 4173-4200

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Chemosensitization and Immunosensitization of Resistant Cancer Cells to Apoptosis and Inhibition of Metastasis by the Specific NF-&kgr;B Inhibitor DHMEQ

By  

Current Pharmaceutical Design, Vol. 15, Iss. 7, 2009-03 ,pp. : 792-808

Bentham Science Publishers

Access to resources Recommend Favorite

Chemosensitization of Cancer by Nitric Oxide

By  

Current Pharmaceutical Design, Vol. 14, Iss. 11, 2008-04 ,pp. : 1113-1123

Bentham Science Publishers

Access to resources Recommend Favorite

NF-&kgr;B as a target for cancer therapy

By Melisi Davide   Chiao Paul J  

Expert Opinion on Therapeutic Targets, Vol. 11, Iss. 2, 2007-02 ,pp. : 133-144

Informa Healthcare

Access to resources Recommend Favorite

Targeting NF-κB for colorectal cancer

By Sakamoto Kei   Maeda Shin  

Expert Opinion on Therapeutic Targets, Vol. 14, Iss. 6, 2010-06 ,pp. : 593-601

Informa Healthcare

Access to resources Recommend Favorite

NF-κB Inhibitors in Head and Neck Cancer

By  

Letters in Drug Design & Discovery, Vol. 14, Iss. 5, 2017-04 ,pp. : 619-633

Bentham Science Publishers

Access to resources Recommend Favorite